Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review
Publication

Publications

Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review

Title
Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review
Type
Another Publication in an International Scientific Journal
Year
2022
Authors
de Matos, PH
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
da Silva, TP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Mansano, AB
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gancedo, NC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Tonin, FS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pelloso, FC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Petruco, MV
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
de Melo, EB
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sanches, ACC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
de Mello, JCP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Chierrito, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Araujo, DCD
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: Inflammation ResearchImported from Authenticus Search for Journal Publications
Vol. 71
Pages: 1489-1500
ISSN: 1023-3830
Publisher: Springer Nature
Other information
Authenticus ID: P-00X-F0E
Abstract (EN): Objective and design The current study aimed to summarize the evidence of compounds contained in plant species with the ability to block the angiotensin-converting enzyme 2 (ACE-II), through a scoping review. Methods PubMed and Scopus electronic databases were used for the systematic search and a manual search was performed Results Studies included were characterized as in silico. Among the 200 studies retrieved, 139 studies listed after the exclusion of duplicates and 74 were included for the full read. Among them, 32 studies were considered eligible for the qualitative synthesis. The most evaluated class of secondary metabolites was flavonoids with quercetin and curcumin as most actives substances and terpenes (isothymol, limonin, curcumenol, anabsinthin, and artemisinin). Other classes that were also evaluated were alkaloid, saponin, quinone, substances found in essential oils, and primary metabolites as the aminoacid l-tyrosine and the lipidic compound 2-monolinolenin. Conclusion This review suggests the most active substance from each class of metabolites, which presented the strongest affinity to the ACE-II receptor, what contributes as a basis for choosing compounds and directing the further experimental and clinical investigation on the applications these compounds in biotechnological and health processes as in COVID-19 pandemic.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 12
Documents
File name Description Size
RIt-206 934.03 KB
Related Publications

Of the same journal

Cancer- and cardiac-induced cachexia: Same fate through different inflammatory mediators? (2022)
Another Publication in an International Scientific Journal
Rita Nogueira-Ferreira; Fábio Sousa-Nunes; Adelino Leite-Moreira; Liliana Moreira-Costa; Rui Vitorino; Lúcio Lara Santos; Daniel Moreira-Gonçalves; Rita Ferreira
The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment (2010)
Article in International Scientific Journal
Lima Rodrigues, M; Lamas, N; Valle Fernandes, A; Cruz, A; Vieira, A; oliveira, p; Pedrosa, J; CASTRO, AG; Reis, RM; Baltazar, F; Almeida, A
Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline (2022)
Article in International Scientific Journal
Lousa, I; Belo, L; Valente, MJ; Rocha, S; Preguica, I; Rocha-Pereira, P; Beirao, I; Mira, F; Alves, R; Reis, F; Alice Santos Silva
Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients (2023)
Article in International Scientific Journal
Reina Couto, M; Roboredo Madeira, M; Pereira Terra, P; Silva Pereira, C; Martins, S; Teixeira Santos, L; Pinho, Dora; Dias, A; Cordeiro, G; Dias C; Sarmento A; Tavares, M; guimaraes, jt; Roncon-Albuquerque R Jr; Paiva, J-A; Albino Teixeira, A; Sousa, T
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-07 at 23:56:14 | Privacy Policy | Personal Data Protection Policy | Whistleblowing